CN Patent

CN121511080A — 一类芳香酰胺类衍生物及其用途

Assigned to Huajian Future Chengdu Technology Co ltd · Expires 2026-02-10 · 0y expired

What this patent protects

一种芳香酰胺类衍生物，其制备方法以及该类化合物在预防和/或治疗疾病，特别是在肿瘤治疗中的应用。该类芳香酰胺类衍生物是MEK/RAF抑制剂，具有较好的活性和安全性等优势，在预防和/或治疗与MAPK通路有关的肿瘤方面显示出较好的应用前景。

USPTO Abstract

一种芳香酰胺类衍生物，其制备方法以及该类化合物在预防和/或治疗疾病，特别是在肿瘤治疗中的应用。该类芳香酰胺类衍生物是MEK/RAF抑制剂，具有较好的活性和安全性等优势，在预防和/或治疗与MAPK通路有关的肿瘤方面显示出较好的应用前景。

Drugs covered by this patent

Patent Metadata

Patent number: CN121511080A
Jurisdiction: CN
Classification: —
Expires: 2026-02-10
Drug substance claim: No
Drug product claim: No
Assignee: Huajian Future Chengdu Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.